MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.
Also called NCT05289947
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 303 participants
- Sponsor
- Moleac Pte Ltd.
- Registry
-
NCT05289947
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Philippines, Singapore
- Registry status
- Completed
Technical summary
Registry record NCT05289947. Randomized; quadruple masking; primary purpose treatment. Start 2023-07-21 (actual); primary completion 2025-07-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
- Acronym
- MAESTOSO
- Condition
- Stroke
- Condition
- Stroke, Ischemic
- Condition
- Strokes Thrombotic
- Condition
- Stroke Sequelae
- Condition
- Stroke, Cardiovascular
- Condition
- Stroke, Embolic
- Condition
- Stroke, Cryptogenic
- Intervention (Other)
- Placebo
- Intervention (Drug)
- MLC1501
- Lead sponsor
- Moleac Pte Ltd.
Record details
- Record id
cardio:ct-nct05289947- Content hash
ce86c54ecad0bb8d21489ce726e183c9919fedfd7c42f775a673e656a5bae9ea